Abera Bioscience AB announced that it will issue 1,114,363 shares at a price of SEK 15.30 per share for gross proceeds of SEK 17,000,000 in a round of funding on June 9, 2021. The transaction will include participation from a group of existing and external qualified investors. The transaction has been approved by the board of directors of the company at its Annual General Meeting.